Other

Research shows gaps in unfit driver reporting

(Medical Xpress)—Ontario doctors are legally required to report patients they consider medically unfit to drive to the Ministry of Transportation (MTO) – yet they may not be doing it.

Oncology & Cancer

Potential drug for treating deadly brain cancer

(Medical Xpress)—A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults − glioblastoma multiforme. The scientists found that by targeting this biomarker and depleting it with ...

Medical research

Improved image analysis for MRI

Reliable, accurate and repeatable analysis of medical images continues to be a challenge in disease treatment. A European research initiative has developed robust and efficient computing techniques for image data interpretation, ...

Medical research

Laser-ing in on brain surgery

Medical operations have become almost commonplace, but the delicacy of medical procedures involving the brain and the spinal cord force physicians and patients to consider other alternatives. European researchers, however, ...

Oncology & Cancer

Genetic markers hope for new brain tumor treatments

Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.

Oncology & Cancer

A better diagnostic tool for brain cancer

A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (NUS), and Singapore Institute for Clinical Sciences (SICS), A*STAR, has uncovered the role of a new tumour suppressor ...

Oncology & Cancer

New drug shrinks brain tumours in melanoma patients

(Medical Xpress) -- Australian researchers have reported promising results with a new drug that shrinks brain tumours in melanoma patients. Their findings are published in The Lancet medical journal today.

Oncology & Cancer

Children's brain tumors more diverse than previously believed

Paediatric brain tumours preserve specific characteristics of the normal cells from which they originate – a previously unknown circumstance with ramifications for how tumour cells respond to treatment. This has been ...

page 20 from 24